What's Going on With AbCellera Biologics Stock On Wednesday?
AbCellera shares rise after positive ABCL635 Phase 2 results, while bullish momentum and analyst price targets point to further upside.
AbCellera's medicine passed an important test (Phase 2), which made people excited about the company. When people feel good about a company's future, they often buy its stock, so watch if that excitement keeps going or fades.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.